These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 31264032)
1. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial. Myasoedova E; Crowson CS; Giblon RE; McCarthy-Fruin K; Schaffer DE; Wright K; Matteson EL; Davis JM Clin Rheumatol; 2019 Nov; 38(11):3025-3032. PubMed ID: 31264032 [TBL] [Abstract][Full Text] [Related]
2. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire. Myasoedova E; De Thurah A; Erpelding ML; Schneeberger EE; Maribo T; Citera G; Davis JM; Matteson EL; Crowson CS; Fautrel B; Guillemin F Semin Arthritis Rheum; 2020 Apr; 50(2):261-265. PubMed ID: 31526593 [TBL] [Abstract][Full Text] [Related]
3. A Novel Mobile App and Population Management System to Manage Rheumatoid Arthritis Flares: Protocol for a Randomized Controlled Trial. Wang P; Luo D; Lu F; Elias JS; Landman AB; Michaud KD; Lee YC JMIR Res Protoc; 2018 Apr; 7(4):e84. PubMed ID: 29643053 [TBL] [Abstract][Full Text] [Related]
4. The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA). Barroso N; Woodworth TG; Furst DE; Guillemin F; Fautrel BJ; Borazan N; Kafaja S; Brook J; Elashoff DA; Ranganath VK Clin Rheumatol; 2020 Jan; 39(1):189-199. PubMed ID: 31493148 [TBL] [Abstract][Full Text] [Related]
5. Cumulative patient-based disease activity monitoring in rheumatoid arthritis - predicts sustained remission, flare and treatment escalation. Leung MH; Choy EHS; Lau CS Semin Arthritis Rheum; 2020 Aug; 50(4):749-758. PubMed ID: 32531504 [TBL] [Abstract][Full Text] [Related]
6. Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study. Kuettel D; Primdahl J; Weber U; Terslev L; Østergaard M; Petersen R; Pedersen AK; Möller S; Hørslev-Petersen K J Rheumatol; 2020 Sep; 47(9):1305-1313. PubMed ID: 31787604 [TBL] [Abstract][Full Text] [Related]
7. Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study. Raheel S; Matteson EL; Crowson CS; Myasoedova E Rheumatology (Oxford); 2017 Dec; 56(12):2154-2161. PubMed ID: 28968703 [TBL] [Abstract][Full Text] [Related]
8. The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial. Roelsgaard IK; Thomsen T; Østergaard M; Christensen R; Hetland ML; Jacobsen S; Andersen L; Tønnesen H; Rollefstad S; Semb AG; Esbensen BA Trials; 2017 Nov; 18(1):570. PubMed ID: 29183347 [TBL] [Abstract][Full Text] [Related]
9. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. Symmons D; Tricker K; Roberts C; Davies L; Dawes P; Scott DL Health Technol Assess; 2005 Sep; 9(34):iii-iv, ix-x, 1-78. PubMed ID: 16153351 [TBL] [Abstract][Full Text] [Related]
10. Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial. Messelink MA; van der Leeuw MS; den Broeder AA; Tekstra J; van der Goes MC; Heijstek MW; Lafeber F; Welsing PMJ Trials; 2022 Jun; 23(1):494. PubMed ID: 35710576 [TBL] [Abstract][Full Text] [Related]
11. Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare. Fautrel B; Morel J; Berthelot JM; Constantin A; De Bandt M; Gaudin P; Maillefert JF; Meyer O; Pham T; Saraux A; Solau-Gervais E; Vittecoq O; Wendling D; Erpelding ML; Guillemin F; Arthritis Rheumatol; 2017 Feb; 69(2):309-319. PubMed ID: 27636400 [TBL] [Abstract][Full Text] [Related]
12. Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials. Holten K; Paulshus Sundlisæter N; Sexton J; Kjørholt KE; Nordberg LB; Moholt E; Uhlig T; van der Heijde D; Solomon DH; Haavardsholm EA; Lillegraven S; Aga AB; RMD Open; 2024 Sep; 10(3):. PubMed ID: 39237295 [TBL] [Abstract][Full Text] [Related]
13. Validation and predictive capacity of a Dutch version of the FLARE-RA questionnaire within the context of a TNFi-tapering trial. Doumen M; Bertrand D; Pazmino S; De Cock D; Stouten V; Joly J; de Wergifosse I; Moeyersoons A; Westhovens R; Verschueren P Clin Rheumatol; 2023 Jan; 42(1):39-45. PubMed ID: 35943667 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients. Bossert M; Prati C; Vidal C; Bongain S; Toussirot E; Wendling D Joint Bone Spine; 2012 Jan; 79(1):57-62. PubMed ID: 21550283 [TBL] [Abstract][Full Text] [Related]
15. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points. Mack ME; Hsia E; Aletaha D Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724 [TBL] [Abstract][Full Text] [Related]
16. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. Alten R; Pohl C; Choy EH; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Sanderson TC; Strand V; Woodworth TG; Bingham CO; J Rheumatol; 2011 Aug; 38(8):1745-50. PubMed ID: 21807796 [TBL] [Abstract][Full Text] [Related]
17. Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial. Ghiti Moghadam M; Vonkeman HE; Ten Klooster PM; Tekstra J; van Schaardenburg D; Starmans-Kool M; Brouwer E; Bos R; Lems WF; Colin EM; Allaart CF; Meek IL; Landewé R; Bernelot Moens HJ; van Riel PL; van de Laar MA; Jansen TL; Arthritis Rheumatol; 2016 Aug; 68(8):1810-7. PubMed ID: 26866428 [TBL] [Abstract][Full Text] [Related]
18. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial. Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762 [TBL] [Abstract][Full Text] [Related]
19. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. van Herwaarden N; van der Maas A; Minten MJ; van den Hoogen FH; Kievit W; van Vollenhoven RF; Bijlsma JW; van den Bemt BJ; den Broeder AA BMJ; 2015 Apr; 350():h1389. PubMed ID: 25858265 [TBL] [Abstract][Full Text] [Related]
20. Definitions of rheumatoid arthritis flare and how they relate to patients' perspectives: A scoping review of qualitative and quantitative evidence. Doumen M; Diricks L; Hermans J; Bertrand D; De Meyst E; Westhovens R; Verschueren P Semin Arthritis Rheum; 2024 Aug; 67():152481. PubMed ID: 38815403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]